Attention Deficit Hiperactivity

Attention-Deficit
H y p e r a c t i v i t y D i s o rd e r a n d
t h e D y s reg u l a t i o n o f Em o t i o n
G e n e r a t i o n a n d Em o t i o n a l
E x p re s s i o n
Joseph C. Blader, PhD
KEYWORDS
Attention-deficit hyperactivity disorder Disruptive mood dysregulation disorder
Oppositional defiant disorder Children Adolescents Aggressive behavior
KEY POINTS
Individuals with attention-deficit/hyperactivity disorder (ADHD) frequently experience
strong reactions to emotionally evocative situations. Difficulties modulating anger and
other upsets have clinically significant behavioral consequences. Among youth with
emotional dysregulation of this type, ADHD is ubiquitous.
There are indications that those with ADHD may have anomalies in emotion generation or
emotion expression that predispose to these problems. It is not established which of these
processes is universally present among those with emotion dysregulation or if instead
different combinations of them yield a variety of clinical phenotypes.
Important conceptual issues concerns in this area include definitions of emotional regula-
tion; whether in some individuals disinhibited, excessive expression of emotion does not
necessarily indicate disturbed emotion generation; the time course of emotion and
behavior among those with and without ADHD; and whether subgrouping on the basis
of behavioral phenotyping, neurofunctional differences, or treatment response can
improve clinical practice.
Initial pharmacotherapy with agents that target ADHD offers, in most cases, an optimal
balance of efficacy and adverse effect liabilities. Use of adjunctive medications is wide-
spread but needs a stronger evidence base. Most current psychosocial treatments
emphasize the reduction of family conflict and promoting improved distress tolerance
and rule adherence; newer approaches that target emotional dysregulation processes
directly are in various phases of development, refinement, and validation.
Department of Psychiatry and Behavioral Sciences, Joe R. and Teresa Lozano Long School of
Medicine, University of Texas Health Science Center at San Antonio, 7703 Floyd Curl Drive, Mail
Stop 7719, San Antonio, TX 78229, USA
E-mail address: [email protected]
Child Adolesc Psychiatric Clin N Am 30 (2021) 349–360

https://doi.org/10.1016/j.chc.2020.10.005 childpsych.theclinics.com
1056-4993/21/ª 2020 Elsevier Inc. All rights reserved.
Descargado para Anonymous User (n/a) en Autonomous University of Bucaramanga de ClinicalKey.es por Elsevier en abril 10, 2021. Para uso
personal exclusivamente. No se permiten otros usos sin autorización. Copyright ©2021. Elsevier Inc. Todos los derechos reservados.
350 Blader
EMOTION DYSREGULATION AND ATTENTION-DEFICIT/HYPERACTIVITY DISORDER
Based on rates of co-occurrence, the association between emotional dysregulation

and attention-deficit/hyperactivity disorder (ADHD) is strong. Approximately 30% to
45% of children with attention-deficit/hyperactivity disorder (ADHD) experience sig-
nificant impairments because they are prone to anger, rageful outbursts, irritability,
aggressive lashing out, or other indicators of dysregulated emotionality.1–3
Conversely, ADHD is ubiquitous among youth who display such emotionally charged
behaviors, with rates over 85% in clinical samples and slightly below in
community.4,5
The association between emotion dysregulation and ADHD, based on the mecha-
nisms that might explain their co-occurrence, however, remains unclear. Why are brit-
tle frustration tolerance and easily triggered tempers so prevalent among those with
ADHD? Do children with these difficulties have something more severe than ADHD?
Are treatments for ADHD bound to be inadequate for them? Could they have a
mood disorder that demands a different approach? Or maybe these behaviors do
not indicate a problem with emotion processes per se; perhaps disinhibited people
experience the same degree of emotional upset that others experience but they just
show more intense, under-controlled behavior in reaction to it.
These questions are at the heart of child mental health practice. Every day clini-
cians encounter a volatile, dysregulated patient with ADHD whose behavior is
deemed to be more than ADHD, who then starts antipsychotic treatment. Every
day a child with lifelong brittle frustration tolerance is prescribed a behavior modifi-
cation plan involving rewards and losses to shape behavior but instead proves to be
another source of upset. Every day a pediatrician is deterred from treating the ADHD
symptoms of a highly explosive patient because she is uncertain about the real un-
derlying problem.
PHENOMENOLOGY AND IMPACT
The outbursts that signify emotion dysregulation often occur after provocations that
age-mates usually handle with composure. Frequent upsets of this sort are disturbing
to others and are not conducive to an enjoyable childhood or a satisfying image of self.
ADHD alone adversely affects quality of life,6 and severe emotion dysregulation further
worsens risks for social rejection, academic failure, family distress, injury, mood and
anxiety disorders, and early mortality.7–10 It is the chief reason children receive anti-
psychotic medications and are psychiatrically hospitalized.11–14
Emotional dysregulation in this context differs from psychiatry’s traditional frame-
work for mood disturbances, such as major depression and bipolar disorder (BD).
This framework emphasizes symptoms periodically coalescing and worsening to
form an episode of illness. During that episode, symptoms are, in general, unremit-
tingly present. Children with ADHD and emotional dysregulation usually show the in-
verse of this picture. They rarely have discrete well-defined episodes of disturbance.
Instead, their susceptibility to affective dyscontrol is consistent over years.
In-between incidents of provoked rage and dyscontrol, when things seem to be
going the child’s preferred way, only a minority show significant mood problems.
The Diagnostic and Statistical Manual of Mental Disorders (Fifth Edition) (DSM-5) intro-
duced the diagnosis of disruptive mood dysregulation disorder (DMDD) within the
depressive disorders rubric. It requires both intermittent rageful outbursts and a
persistent mood disturbance (ie, irritable or angry mood most of the time). In clinical
samples of children with ADHD and frequent but intermittent rage outbursts, up to
30% also have the persistent angry or irritable mood that DMDD requires.15–17
Emotion Generation and Emotional Expression 351
HISTORY AND DIAGNOSTIC PRACTICES
Well before ADHD became formalized as a diagnosis,18 drastic displays of anger,

reactive aggression, and weakly restrained emotional expression were known to be
common among children with impulse control deficits. For most of the twentieth cen-
tury, abnormally intense expressions of emotion were included in descriptions of chil-
dren with ADHD symptoms.19 Emotion-related problems essentially were defined out
of ADHD, implicitly in the Diagnostic and Statistical Manual of Mental Disorders (Sec-
ond Edition) and explicitly in the Diagnostic and Statistical Manual of Mental Disorders
(Third Edition) (DSM-III), as the emphasis on the disorder shifted toward cognitive
functions that could be measured in laboratory settings.19 DSM-III’s introduction of
oppositional defiant disorder (ODD) provided a rubric for some affective features
frequent in ADHD; 4 of its 8 behavioral criteria involve affect.
In time, ADHD came to denote a problem of inattention and overactivity. ODD like-
wise evoked an image of bratty insubordination, a mere behavior problem, regarded
by some observers as not quite a real psychiatric illness. In this context, concerns
arose that ADHD and ODD underemphasized the affective disturbances so prominent
among children with severe behavioral dyscontrol, many of whom required psychiatric
hospitalization. To compensate, it became common to diagnose this presentation as a
form of BD. This linkage, however, introduced its own set of difficulties, including vast
inflation of BD’s incidence among youth in the United States.20,21 DMDD was
designed partly to offer an alternative mood disorder rubric for these problems that
avoided this and other concerns.
Currently, emotion regulation has developed as a focus of research interest in its
own right.22 Its relationship to ADHD is a significant area of emphasis,23–25 as research
has helped recast ADHD as a pervasive inadequacy of self-regulatory functions.
Because only a minority of those with ADHD demonstrate severe emotion dysregula-
tion, however, it is hard to maintain that emotional dysregulation is integral to ADHD or
that ADHD is a sufficient cause for it. Understanding how problems in impulse control
contribute to emotional disturbances for a subgroup of children is now a significant
area of investigation.
CONCEPTUAL ISSUES
What Are the Elements of Emotion Regulation?
It is challenging to define emotion, which makes any definition of its dysregulation pro-
visional at best. People differ in their susceptibility to certain mood states and in how
these states affect observable behaviors. The regulatory processes that determine
these differences remain uncertain. There likely is some process at work that enables
a person to move on from an emotion-engaging event that is not resolved to the per-
son’s liking instead of dwelling on it. These processes are thought to involve some
combination of explicit, effortful skills, such as reframing and reappraisal, and more
automatic or implicit skills, such as habituation or distraction.26–28
Another framework for emotion-related processes distinguishes emotion generation
from emotional expression. It resembles the common separation of bottom-up from
top-down processes.24 The next sections briefly review some ways both processes
can be disrupted in ADHD.
Emotion Generation
Neurofunctional accounts of anger identify significant roles for responses to threat,
reward, and frustration.25,29 Some studies suggest that there are patterns of response
that are specific to emotion dysregulation rather than generic to ADHD. For instance,
352 Blader
measuring amygdalar reactivity to pictures of angry and neutral faces is a common

paradigm to probe threat-related responses. Severely dysregulated youth with
ADHD showed amygdala hypoactivity to neutral faces, whereas those with ADHD-
only showed hyperactivation.30 Within an ADHD sample, Hulvershorn and col-
leagues31 found that higher amygdala-frontal connectivity correlated with irritability
ratings, controlling for ADHD symptoms. Wiggins and colleagues32 reported greater
amygdala hypoactivation to intensely angry faces among more severely irritable sub-
jects with DMDD whereas those with less irritability demonstrated hyperactivation;
ADHD was present in 56% of DMDD participants but it was not tested as a moderator.
Amygdala hypoactivation also is found in youth with callous-unemotional traits
compared with those with ADHD but no conduct disturbance.33
Neural sensitivity to rewarding stimuli has been compared in several clinical and
control groups. Aberrant connectivity34 and hyporeactivity to reward anticipation35
are reported among children with ADHD relative to controls. The experience of frustra-
tion is modeled in experimental settings by withholding a reward that a participant ex-
pects. Deveney and colleagues36 found greater striatal deactivation during a
frustrating event among severely mood dysregulated children than in a comparison
group; 79% of this sample had ADHD. Low sensitivity to rewarding stimuli and greater
shutdown of reward processing areas during frustration may predispose to irritability.
These features might leave a person in a more dysphoric state because the hedonic
setpoint requires more intense or frequent rewards than most daily life situations
provide.
Stimulus novelty is thought be valued by those with ADHD, who may need more of it
to maintain a level of optimal stimulation.37,38 In ordinary situations that do not feature
high stimulation, novelty, and interest, it suspected that the tedium and discomfort
those with ADHD experience might contribute to their higher risk of irritability.39
Some cognitive deficits common in ADHD, such as working memory, may hamper
adaptation to new reward contingencies. This in turn leads to perseveration of behav-
iors that are ineffective in obtaining desired outcomes and therefore amplifies frustra-
tion (reviewed by Leibenluft25).
Patients with ADHD also may have anomalous reactivity to alert signals in their en-
vironments. Studies of brain functional connectivity identify a salience network that
comprises bilateral insular cortex and anterior cingulate gyrus.40 In ADHD, this
network41 demonstrates abnormally high functional connectivity with the default
mode and dorsal attention networks. These associations may contribute toward exag-
gerating the personal significance of events and promoting hyperreactivity. It is un-
clear whether this is a generic feature of ADHD or is more prominent among those
with emotional dysregulation.
There also are effortful processes through which people regulate emotion genera-
tion. These include things to prevent unwanted emotional activation in the first place
or to raise the likelihood of experiencing desirable events. People actively select,
avoid, or modify situations and prepare for the emotional impact of events they can
anticipate.42,43 Planning and foresight often are underdeveloped or underutilized by
youth and adults with ADHD. The low distress tolerance observed in ADHD might
result in part from deficits in this form of anticipatory planning. For instance, a person
may fail to anticipate and manage future disappointment when the chances for goal
attainment are low.
Emotion Expression
It is easy to envision how poor response inhibition could lead to emotionally charged
behavior that appears excessive. People often infer the strength of others’ emotion
from the intensity of behaviors that expresses it. Weak behavioral self-control that am-
plifies this expression of emotion leads to the perception that the underlying emotion is
stronger compared with someone whose behavioral reaction is more muted. In cases
of anger, individuals obviously are distressed, but a fair question is whether they have
(1) a significant disturbance in mood or emotion generation per se or (2) difficulty cur-
tailing behavioral outflow in responding to situations most people would find equally
unpleasant but display less overt upset.
The issue relates in part to the imperfect correlation between 3 emotion response
domains of subjective experience (including cognition), behavior, and autonomic
physiology. Weak concordance between these response systems for several
emotional states has been demonstrated in adults,44,45 and similar results are seen
for children and adolescents.46,47 As an example of response system desynchrony,
Faraone and colleagues48 note, “it seems inappropriate to say that the stoic, unex-
pressive mourner is necessarily less grief-stricken than the sobbing one.”
Viewing emotion dysregulation in ADHD as poorly modulated expression is parsi-
monious. The idea highlights ADHD’s top-down self-regulatory deficits without having
to invoke a separate disturbance of affect regulation. It also helps account for intense
expressions of both positively and negatively valenced emotion observed in
ADHD.19,48 A majority of those with ADHD, however, do not display significant
emotional dysregulation. Of course, few disorders have homogeneous presentations;
the last part of this section takes up the issue of heterogeneity in ADHD’s association
with emotion dysregulation.
The Time Course of Emotion and Behavior

The traditional concepts of mood disorders in psychiatry emphasize pervasive, fairly
stable symptoms during an episode. The concept of emotion dysregulation is broader,
and, at least in child psychiatry, has focused more on emotional reactivity to situational
provocations than on sustained disturbances in hedonic tone, outlook on the future
and self, and so forth.
Emotion and behavior in these incidents have temporal features that include range,
latency, rise time, peak intensity, and recovery time; collectively, they make the affec-
tive chronometry of a response.49,50 These aspects of emotional reactivity have been
examined mainly by developmental psychologists and emotion researchers, while
largely neglected in clinical psychiatry literature. They seem highly relevant to
ADHD, however, because impulsivity itself has a temporal dimension that may influ-
ence emotional reactions.
One framework applies these temporal characteristics separately to emotion gener-
ation and emotional expression.48 In the context of ADHD, it proposes that emotional
impulsivity is associated with (1) fast rise times for subjectively experienced emotion
and (2) behavioral disinhibition that promotes more intense expression. Recovery
time from a high peak intensity may take longer than in non-ADHD individuals but is
nonetheless fairly complete. This pattern contrasts with reactivity in more pervasive
mood disorders, in which baseline state already is negative and a noxious event inten-
sifies dysphoria or anger, but behavioral expression is not generally as forceful as in
ADHD with dysregulation.
Heterogeneity in Phenotypes and Mechanisms

The presence and degree of emotional dysregulation are characteristics that demon-
strate wide variation among those with ADHD. Emerging data suggest that youth with
ADHD and emotional dysregulation could represent a subgroup of ADHD with distinct
neural and temperamental correlates.2
354 Blader
Within the group of patients with ADHD and emotion dysregulation, there might be
diverse mechanisms that produce this apparently similar phenotype. Differences in
the origins for emotion dysregulation may have implications for treatment. For
instance, if a subgroup of children show emotion dysregulation because of weak
response control, one prediction is that these symptoms should respond to stimulant
treatment just as other aspects of behavioral inhibition improve with it.24 This is the
case for a large number of children with ADHD, emotional dysregulation, and aggres-
sive behavior who receive structured titration of stimulant medication and brief psy-
chosocial treatment; in 2 trials, more than half of children displayed remission of
aggressive behavior and marked improvements in emotion-related symptoms,
including anger and irritability.15,51,52 Study participants whose aggressive behavior
did not remit nevertheless did show improvement on core ADHD symptoms (hyperac-
tivity, inattention, and impulsiveness). The nonremitters randomized to additional
treatment with risperidone or divalproex sodium show greater improvements in
aggression and mood than those randomized to placebo. Such results suggest het-
erogeneity in the processes that underlie emotion dysregulation in ADHD.
It is tempting, if simplifying, to suspect that patients with strong response to stimu-
lant medications have a form of emotional dysregulation that reflects the general def-
icits in behavioral inhibition that characterize ADHD. The emotional dysregulation of
stimulant nonresponders, in contrast, may indicate a pathogenesis in which
emotion-generating, bottom-up processes are compromised.
ASSESSMENT CONSIDERATIONS FOR ATTENTION-DEFICIT/HYPERACTIVITY

DISORDER AND EMOTION DYSREGULATION
This section highlights a few considerations in the clinical evaluation of patients with
ADHD and features of emotion dysregulation. The discussion assumes the presence
of ADHD has been validated and there are no major developmental concerns.
If parents are asked whether a child is “easily irritated” or “often irritable” the answer
likely is yes, partly because they are focused on incidents of upsets, defiance, and
inflexibility with seemingly minor provocations. This does not mean, however, that ir-
ritability or anger is the patient’s prevailing mood, as is the case in a true mood disor-
der. It, therefore, is worthwhile to consider how dysregulation incidents differ from the
child’s baseline mood and the contexts in which they occur. Questions to pose
include, “Does he seem pretty content when things seem to be going his way, or is
he grouchy even at those times?” “When good things happen, how much does she
seem to enjoy herself, or is she still negative or hard to please?” “Can you usually
figure out what sets him off, or does he sometimes seem to become upset from out
of nowhere?” “When she’s starting to have a meltdown and you give into what she
wants, does that change her mood, or does she still seem pretty mad for a long
while?” and “If no one is doing anything to get on your nerves, do you still feel kind
of annoyed or have a negative attitude that’s hard to shake? Do you keep thinking
about things that annoy you even if there’s nobody bugging you at the moment?”
It also should be determined if low self-esteem, feelings of worthlessness, or self-
harm preoccupation pervade even times of apparent calm. Weepiness, anhedonia,
and sadness are less common in this patient group and may be more suggestive of
depression.15
ADHD’s comorbidity with anxiety disorders is high, and the trimorbidity involving
these conditions with disruptive disorders also is significant. For these patients, out-
bursts that occur only in anxiety-provoking situations for the disorder (eg, at times
of parental separation, when obsessive-compulsive disorder urges are blocked, and
so forth) may be a complication of the anxiety disorder rather than more extensive
emotion dysregulation. Similarly, outbursts around school or academic func-
tioning—especially those that persists after treatment of attentional problems—can
indicate a need to assess for a learning disorder.
It is not uncommon for more extreme outbursts to occur at home but not elsewhere.
It is possible that this is more prevalent among children with anxiety, for whom feeling
evaluated and judged by peers and other nonfamily may have an inhibitory effect.53
Although literature is limited, some trial data and clinical experience suggest that
stimulant medications at times may cause or worsen irritability or dysphoria. Such af-
fective toxicity often is a dose-dependent phenomenon, and some amphetamine-
based products may pose higher risk.54 Antidepressants may have a similar effect:
an inpatient trial reported high rates of increased aggressive behavior among youth
with severe mood dysregulation who received citalopram added to stimulant medica-
tion.55 Clinicians also should be mindful of nonpsychiatric medications’ potential to
affect mood, including corticosteroids and certain antiepileptic drugs.56
Several rating scales for emotional dysregulation for use with children and adults are
listed in a recent review by Faraone and colleagues.48 It is important to obtain initial
and follow-up data for both ADHD symptoms per se and for emotion-dysregulated dif-
ficulties. Some brief rating scales have separate subscales, along with norms, such as
the 10-item Conners Global Index. Where gradations in aggressive behavior are the
principal outcome, there are a few aggression-specific tools, including the
Retrospective-Modified Overt Aggression Scale51 and the Children’s Aggression
Scale.57
TREATMENT CONSIDERATIONS FOR ATTENTION-DEFICIT/HYPERACTIVITY

DISORDER WITH EMOTION DYSREGULATION
Pharmacotherapy
There are few data on the treatment of youth with ADHD who also have emotional dys-
regulation. A somewhat larger literature is available for ADHD with impulsive aggres-
sion, which is relevant for the management of emotional dysregulation. Consensus
guidelines58,59 and clinical trial findings51,52,55,60 indicate that medication that target
ADHD symptoms usually should be first-line treatment. First, there is a good chance
that stimulant treatment alone improves ADHD symptoms, aggressive behavior,
emotional dysregulation, and irritability. Second, problems with inattentiveness, rest-
lessness, and impulsiveness typically require treatment anyway because other med-
ications that target impulsive aggression are less efficacious for these symptoms.
Third, the adverse effect risk profile for stimulant treatment generally is favorable.
Fourth, with improved impulse control, attention span, and frustration tolerance, psy-
chosocial treatments are more likely to gain traction.
Approaches that include a titration protocol with prompt dose adjustments to
improve response and tolerability avoid premature abandonment of a stimulant medi-
cation and are associated with high rates of remission of aggressive behavior and
affect problems.15,51 Situations that warrant greater caution in dosing and monitoring
include patients with autism spectrum disorders and severe anxiety disorder who are
susceptible to worsening of symptoms and, in the case of autism spectrum disorder,
hyperacusis.
When impulsive aggressive behavior does not reduce adequately with optimized
first-line stimulant medications, there are supportive data for the adjunctive use of
the second-generation antipsychotic (SGA) risperidone and the anticonvulsant/
mood stabilizer divalproex sodium. Risperidone’s propensity for weight gain was
356 Blader
observed in these studies, exceeding that for divalproex sodium. Other SGAs with few
data include aripiprazole and quetiapine, although the latter’s efficacy seems weak
even in open trials. Lithium was reported efficacious relative to placebo in a trial for
youth with BD,61 and, along with early inpatient studies showing benefits for aggres-
sion, it also may help with emotional dysregulation that does not respond fully to stim-
ulant treatment.
It is reasonable to suspect that if DMDD is classified as a depressive disorder, pa-
tients with emotional dysregulation might benefit from antidepressant treatment. An
inpatient trial of adjunctive citalopram versus placebo for children with severe mood
dysregulation who already had treatment with methylphenidate reported that 35%
of those receiving citalopram were rated by staff as improved, compared with 6%
receiving placebo.55 Overall assessment of function was improved minimally over
the trial’s 8 weeks, with no difference between groups.
The noradrenergic a2 receptor agonists guanfacine and clonidine are second-line
treatments of ADHD and long have been used as stimulant adjuncts for disruptive
behavior symptoms and aggressive behavior. What they contribute beyond optimized
stimulant treatment among highly emotionally dysregulated patients is unclear. There
is a significant need for stepped treatment trials that evaluate their efficacy in this
context because their adverse effect liabilities are more favorable than SGAs or anti-
epileptic drugs. Of the 2, clonidine is by far the more potent antihypertensive; this
property is related to its high affinity for an imidazoline receptor (I1), which is irrelevant
to its psychotropic activity. Guanfacine’s binding profile shows greater specificity for
a2 receptors.
Psychosocial Treatments
Family-based behavioral treatments have been widely employed and studied in the
treatment of disruptive behavior problems. They share emphases on (1) improving
the parent-child relationship to become less conflictual and prone to mutual escalation
over minor misbehavior, (2) improving communication and incentive to promote more
cooperative behavior (giving directions constructively, praise and reward systems,
and so forth), and (3) firm but nonhostile setting of limits and management of negative
behaviors. Relative to no-treatment controls, large effect sizes for child behavioral
improvement have been reported.[**] With very volatile and dysregulated children,
these interventions need to be monitored so that strategies are implemented at
home without exacerbating conflict. Some consequence-based approaches may
prove inflammatory for children with minimal frustration tolerance. Contingencies
and expectations have to be calibrated so that in a given situation the sequence of
antecedent / target behavior (compliance and composure) / reward is highly likely.
Treatments that target emotion dysregulation specifically are being developed,
refined, and studied gradually. Some are adaptations of dialectical behavior therapy,
one of the leading interventions for borderline personality disorder.62 Anger manage-
ment approaches may be helpful, but many children with ADHD are deficient in the
anticipatory self-awareness to monitor building rage and modulate their appraisals
or responses in the brief interval that their short fuses afford. In these cases, initial
treatment of ADHD might make these interventions more viable.
Anxiety disorder treatment capitalizes on the fact that exposure to stimuli long
enough for arousal to extinguish reduces anxiety and apprehensiveness in subse-
quent exposures. Extending this reasoning to anger and emotion dysregulation,
another approach is to work with families so that patients gradually are exposed to
anger-provoking situations in a hierarchy that progresses from less provocative to
more.63
SUMMARY
Growing appreciation that the self-regulatory deficits that characterize ADHD and
other externalizing problems also have an impact on emotion-related functions has
sparked interest on the interdependence of affective, executive control, and
behavior-regulating processes. These processes may vary between patients. A similar
trend in adult psychopathology has revealed the triangulation of affect dysregulation,
executive control, and substance abuse,64 whereas the specific neural functions that
underly the relationship differ between subgroups of patients.
As analyses of processes that underlie emotional regulation become more sophis-
ticated, they may reveal distinct pathogenic pathways for impulsive, emotionally dys-
regulated individuals. The robust response to first-line stimulant and behavioral
treatments that many children with these difficulties experience, while other children
remain highly impaired, hints at heterogeneity of mechanisms. Further refinement of
these processes and capacity to identify them in routine clinical care will contribute
to more judicious, safer, and effective care of one of the most vulnerable patient
groups.
DISCLOSURE
The author has nothing to disclose.
REFERENCES
1. Liu L, Chen W, Vitoratou S, et al. Is emotional lability distinct from "angry/irritable

mood," "negative affect," or other subdimensions of oppositional defiant disorder
in children with ADHD? J Atten Disord 2019;23(8):859–68.
2. Karalunas SL, Fair D, Musser ED, et al. Subtyping attention-deficit/hyperactivity
disorder using temperament dimensions: toward biologically based nosologic
criteria. JAMA Psychiatry 2014;71(9):1015–24.
3. Stringaris A, Goodman R. Mood lability and psychopathology in youth. Psychol
Med 2009;39(8):1237–45.
4. Axelson D, Findling RL, Fristad MA, et al. Examining the proposed disruptive
mood dysregulation disorder diagnosis in children in the Longitudinal Assess-
ment of Manic Symptoms study. J Clin Psychiatry 2012;73(10):1342–50.
5. Leibenluft E. Severe mood dysregulation, irritability, and the diagnostic bound-
aries of bipolar disorder in youths. Am J Psychiatry 2011;168(2):129–42.
6. Coghill D, Hodgkins P. Health-related quality of life of children with attention-
deficit/hyperactivity disorder versus children with diabetes and healthy controls.
Eur Child Adolesc Psychiatry 2016;25(3):261–71.
7. Copeland WE, Shanahan L, Egger H, et al. Adult diagnostic and functional out-
comes of DSM-5 disruptive mood dysregulation disorder. Am J Psychiatry
2014;171(6):668–74.
8. Fang X, Massetti GM, Ouyang L, et al. Attention-deficit/hyperactivity disorder,
conduct disorder, and young adult intimate partner violence. Arch Gen Psychiatry
2010;67(11):1179–86.
9. Dalsgaard S, Ostergaard SD, Leckman JF, et al. Mortality in children, adoles-
cents, and adults with attention deficit hyperactivity disorder: a nationwide cohort
study. Lancet 2015;385(9983):2190–6.
10. Bagwell CL, Molina BS, Pelham WE Jr, et al. Attention-deficit hyperactivity disor-
der and problems in peer relations: predictions from childhood to adolescence.
J Am Acad Child Adolesc Psychiatry 2001;40(11):1285–92.
358 Blader
11. Birnbaum ML, Saito E, Gerhard T, et al. Pharmacoepidemiology of antipsychotic

use in youth with ADHD: trends and clinical implications. Curr Psychiatry Rep
2013;15(8):1–13.
12. Olfson M, King M, Schoenbaum M. Treatment of young people with antipsychotic
medications in the United States. JAMA Psychiatry 2015;72(9):867–74.
13. Blader JC. Acute inpatient care for psychiatric disorders in the United States,
1996 through 2007. Arch Gen Psychiatry 2011;68(12):1276–83.
14. Kreider AR, Matone M, Bellonci C, et al. Growth in the concurrent use af antipsy-
chotics with other psychotropic medications in Medicaid-enrolled children. J Am
Acad Child Adolesc Psychiatry 2014;53(9):960–70.
15. Blader JC, Pliszka SR, Kafantaris V, et al. Prevalence and treatment outcomes of
persistent negative mood among children with attention-deficit/hyperactivity dis-
order and aggressive behavior. J Child Adolesc Psychopharmacol 2016;26(2):
164–73.
16. Roy AK, Lopes V, Klein RG. Disruptive mood dysregulation disorder: a new diag-
nostic approach to chronic irritability in youth. Am J Psychiatry 2014;171(9):
918–24.
17. Roy AK, Klein RG, Angelosante A, et al. Clinical features of young children
referred for impairing temper outbursts. J Child Adolesc Psychopharmacol
2013;23(9):588–96.
18. American Psychiatric Association. Diagnostic and Statistical Manual of Mental
Disorders. 3rd ed. Washington, DC: American Psychiatric Association; 1980.
19. Barkley RA. Emotional dysregulation is a core component of ADHD. In:
Barkley RA, editor. Attention-deficit hyperactivity disorder: a handbook for diag-
nosis and treatment. 4th edition. New York: Guilford Press; 2015. p. 81–115.
20. Blader JC, Carlson GA. Increased rates of bipolar disorder diagnoses among
U.S. child, adolescent, and adult inpatients, 1996-2004. Biol Psychiatry 2007;
62(2):107–14.
21. Moreno C, Laje G, Blanco C, et al. National trends in the outpatient diagnosis and
treatment of bipolar disorder in youth. Arch Gen Psychiatry 2007;64(9):1032–9.
22. Ochsner KN, Gross JJ. The neural bases of emotion and emotion regulation: a
valuation perspective. In: Gross JJ, editor. Handbook of emotion regulation.
2nd edition. New York: Guilford; 2014. p. 23–43.
23. Graziano PA, Garcia A. Attention-deficit hyperactivity disorder and children’s
emotion dysregulation: a meta-analysis. Clin Psychol Rev 2016;46:106–23.
24. Shaw P, Stringaris A, Nigg J, et al. Emotion dysregulation in attention deficit hy-
peractivity disorder. Am J Psychiatry 2014;171(3):276–93.
25. Leibenluft E. Pediatric irritability: a systems neuroscience approach. Trends Cogn
Sci 2017;21(4):277–89.
26. Gyurak A, Gross JJ, Etkin A. Explicit and implicit emotion regulation: a dual-
process framework. Cogn Emot 2011;25(3):400–12.
27. Ochsner KN, Ray RR, Hughes B, et al. Bottom-up and top-down processes in
emotion generation: common and distinct neural mechanisms. Psychol Sci
2009;20(11):1322–31.
28. Mauss IB, Levenson RW, McCarter L, et al. The tie that binds? Coherence among
emotion experience, behavior, and physiology. Emotion 2005;5(2):175–90.
29. Blair RJR. Considering anger from a cognitive neuroscience perspective. Wiley
Interdiscip Rev Cogn Sci 2012;3(1):65–74.
30. Brotman MA, Rich BA, Guyer AE, et al. Amygdala activation during emotion pro-
cessing of neutral faces in children with severe mood dysregulation versus ADHD
or bipolar disorder. Am J Psychiatry 2010;167(1):61–9.
31. Hulvershorn LA, Mennes M, Castellanos FX, et al. Abnormal amygdala functional
connectivity associated with emotional lability in children with attention-deficit/
hyperactivity disorder. J Am Acad Child Adolesc Psychiatry 2014;53(3):351–61.
32. Wiggins JL, Brotman MA, Adleman NE, et al. Neural correlates of irritability in
disruptive mood dysregulation and bipolar disorders. Am J Psychiatry 2016;
173(7):722–30.
33. Marsh AA, Finger EC, Mitchell DG, et al. Reduced amygdala response to fearful
expressions in children and adolescents with callous-unemotional traits and
disruptive behavior disorders. Am J Psychiatry 2008;165(6):712–20.
34. Costa Dias TG, Wilson VB, Bathula DR, et al. Reward circuit connectivity relates
to delay discounting in children with attention-deficit/hyperactivity disorder. Eur
Neuropsychopharmacol 2013;23(1):33–45.
35. Scheres A, Milham MP, Knutson B, et al. Ventral striatal hyporesponsiveness dur-
ing reward anticipation in attention-deficit/hyperactivity disorder. Biol Psychiatry
2007;61(5):720–4.
36. Deveney CM, Connolly ME, Haring CT, et al. Neural mechanisms of frustration in
chronically irritable children. Am J Psychiatry 2013;170(10):1186–94.
37. Antrop I, Roeyers H, Van Oost P, et al. Stimulation seeking and hyperactivity in
children with ADHD. Attention deficit hyperactivity disorder. J Child Psychol Psy-
chiatry 2000;41(2):225–31.
38. Zentall SS, Zentall TR. Optimal stimulation: a model of disordered activity and
performance in normal and deviant children. Psychol Bull 1983;94(3):446–71.
39. Wilbertz G, Trueg A, Sonuga-Barke EJS, et al. Neural and psychophysiological
markers of delay aversion in attention-deficit hyperactivity disorder. J Abnorm
Psychol 2013;122(2):566–72.
40. Uddin LQ. Salience processing and insular cortical function and dysfunction. Nat
Rev Neurosci 2015;16(1):55–61.
41. Sidlauskaite J, Sonuga-Barke E, Roeyers H, et al. Altered intrinsic organisation of
brain networks implicated in attentional processes in adult attention-deficit/
hyperactivity disorder: a resting-state study of attention, default mode and
salience network connectivity. Eur Arch Psychiatry Clin Neurosci 2016;266(4):
349–57.
42. Gross JJ, Barrett LF. Emotion generation and emotion regulation: one or two de-
pends on your point of view. Emot Rev 2011;3(1):8–16.
43. Thompson RA. Emotion and emotion regulation: two sides of the developing coin.
Emot Rev 2011;3(1):53–61.
44. Lanteigne DM, Flynn JJ, Eastabrook JM, et al. Discordant patterns among
emotional experience, arousal, and expression in adolescence: relations with
emotion regulation and internalizing problems. Can J Behav Sci 2014;46(1):
29–39.
45. Mauss IB, Robinson MD. Measures of emotion: a review. Cogn Emot 2009;23(2):
209–37.
46. Benoit Allen K, Allen B, Austin KE, et al. Synchrony–desynchrony in the tripartite
model of fear: predicting treatment outcome in clinically phobic children. Behav
Res Ther 2015;71(Supplement C):54–64.
47. Smith M, Hubbard JA, Laurenceau JP. Profiles of anger control in second-grade
children: examination of self-report, observational, and physiological compo-
nents. J Exp Child Psychol 2011;110(2):213–26.
48. Faraone SV, Rostain AL, Blader J, et al. Practitioner Review: emotional dysregu-
lation in attention-deficit/hyperactivity disorder - implications for clinical recogni-
tion and intervention. J Child Psychol Psychiatry 2019;60(2):133–50.
360 Blader
49. Thompson RA. Emotion and self-regulation. In: Thompson RA, editor. Socioemo-
tional development. Nebraska symposium on motivation 1988, vol. 36. Lincoln
(NE): University of Nebraska Press; 1990. p. 367–467.
50. Lamm C, Granic I, Zelazo PD, et al. Magnitude and chronometry of neural mech-
anisms of emotion regulation in subtypes of aggressive children. Brain Cogn
2011;77(2):159–69.
51. Blader JC, Pliszka SR, Kafantaris V, et al. Stepped treatment for attention-deficit/
hyperactivity disorder and aggressive behavior: a randomized, controlled trial of
adjunctive risperidone, divalproex sodium, or placebo after stimulant medication
optimization. J Am Acad Child Adolesc Psychiatry 2020. https://doi.org/10.1016/j.
jaac.2019.12.009.
52. Blader JC, Schooler NR, Jensen PS, et al. Adjunctive divalproex versus placebo
for children with ADHD and aggression refractory to stimulant monotherapy. Am J
Psychiatry 2009;166(12):1392–401.
53. Carlson GA, Blader JC. Diagnostic implications of informant disagreement for
manic symptoms. J Child Adolesc Psychopharmacol 2011;21(5):399–405.
54. Stuckelman ZD, Mulqueen JM, Ferracioli-Oda E, et al. Risk of irritability with psy-
chostimulant treatment in children with ADHD: a meta-analysis. J Clin Psychiatry
2017;78(6):e648–55.
55. Towbin K, Vidal-Ribas P, Brotman MA, et al. A double-blind randomized placebo-
controlled trial of citalopram adjunctive to stimulant medication in youth with
chronic severe irritability. J Am Acad Child Adolesc Psychiatry 2020;59(3):
350–61.
56. Halma E, de Louw AJ, Klinkenberg S, et al. Behavioral side-effects of levetirace-
tam in children with epilepsy: a systematic review. Seizure 2014;23(9):685–91.
57. Halperin JM, McKay KE, Newcorn JH. Development, reliability, and validity of the
children’s aggression scale-parent version. J Am Acad Child Adolesc Psychiatry
2002;41(3):245–52.
58. Pliszka SR, Crismon ML, Hughes CW, et al. The Texas Children’s Medication Al-
gorithm Project: revision of the algorithm for pharmacotherapy of attention-deficit/
hyperactivity disorder. J Am Acad Child Adolesc Psychiatry 2006;45(6):642–57.
59. Scotto Rosato N, Correll CU, Pappadopulos E, et al. Treatment of maladaptive
aggression in youth: CERT Guidelines II. Treatments and ongoing management.
Pediatrics 2012;129(6):e1577–86.
60. Aman MG, Bukstein OG, Gadow KD, et al. What does risperidone add to parent
training and stimulant for severe aggression in child attention-deficit/hyperactivity
disorder? J Am Acad Child Adolesc Psychiatry 2014;53(1):47–60.
61. Findling RL, Robb A, McNamara NK, et al. Lithium in the acute treatment of bipo-
lar I disorder: a double-blind, placebo-controlled study. Pediatrics 2015;136(5):
885–94.
62. Perepletchikova F, Nathanson D, Axelrod S, et al. Randomized clinical trial of dia-
lectical behavior therapy for pre-adolescent children with disruptive mood dysre-
gulation disorder: feasibility and outcomes. J Am Acad Child Adolesc Psychiatry
2017;56(10):832–40.
63. Kircanski K, Craske MG, Averbeck BB, et al. Exposure therapy for pediatric irri-
tability: theory and potential mechanisms. Behav Res Ther 2019;118:141–9.
64. Wilcox CE, Pommy JM, Adinoff B. Neural circuitry of impaired emotion regulation
in substance use disorders. Am J Psychiatry 2016;173(4):344–61.

Attention Deficit Hiperactivity

Uploaded by

Copyright:

Available Formats

Attention Deficit Hiperactivity

Uploaded by

Document Information

Copyright

Available Formats

Share this document

Share or Embed Document

Sharing Options

Did you find this document useful?

Is this content inappropriate?

Copyright:

Available Formats

Attention Deficit Hiperactivity

Uploaded by

Copyright:

Available Formats

Attention-Deficit

Child Adolesc Psychiatric Clin N Am 30 (2021) 349–360

EMOTION DYSREGULATION AND ATTENTION-DEFICIT/HYPERACTIVITY DISORDER

Based on rates of co-occurrence, the association between emotional dysregulation

PHENOMENOLOGY AND IMPACT

HISTORY AND DIAGNOSTIC PRACTICES

Well before ADHD became formalized as a diagnosis,18 drastic displays of anger,

measuring amygdalar reactivity to pictures of angry and neutral faces is a common

The Time Course of Emotion and Behavior

Heterogeneity in Phenotypes and Mechanisms

ASSESSMENT CONSIDERATIONS FOR ATTENTION-DEFICIT/HYPERACTIVITY

TREATMENT CONSIDERATIONS FOR ATTENTION-DEFICIT/HYPERACTIVITY

The author has nothing to disclose.

1. Liu L, Chen W, Vitoratou S, et al. Is emotional lability distinct from "angry/irritable

11. Birnbaum ML, Saito E, Gerhard T, et al. Pharmacoepidemiology of antipsychotic

You might also like